首页/数据集/Primary motivations for publishing adverse drug reactions.

Primary motivations for publishing adverse drug reactions.

NIAID Data Ecosystem2026-03-11 收录

不良反应报告

药物警戒

数据链接：

https://figshare.com/articles/dataset/Primary_motivations_for_publishing_adverse_drug_reactions_/9200459 数据链接链接失效反馈

官方服务：

资源简介：

Primary motivations for publishing adverse drug reactions.

应用场景：

创建时间：

2019-07-31

用药安全

药物警戒

Abstract Background: Temozolomide is a widely used chemotherapy agent for the treatment of malignant gliomas and other brain tumors. Despite its established therapeutic benefits, there is an ongoing

DataCite Commons2024-12-05 更新50

Retrospective AEs found during AE form review.

药物警戒

不良事件

Retrospective AEs found during AE form review.

Figshare2019-06-10 更新20

Table 2_Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.xlsx

药物警戒

药物诱导肾结石风险

ObjectiveThis study aims to identify the drugs most commonly associated with kidney stone-related adverse events using data from the FDA Adverse Event Reporting System (FAERS), providing insights for

NIAID Data Ecosystem10

Adverse events associated with biologics approved for gMG use

药物警戒

重症肌无力

his dataset supports a real-world pharmacovigilance study that evaluates and compares adverse events (AEs) associated with five biologics—efgartigimod, rozanolixizumab, eculizumab, ravulizumab, and zi

Figshare2025-05-30 更新20

A two by two table for the adverse event-drug pair.

药物警戒

不良反应信号检测

*AE = Adverse Event; a = the number of reports involving the drug of interest j and adverse event of interest i combination; b = reports of adverse event of interest i observed with other drugs; c = r

Figshare2015-12-02 更新10

Primary motivations for publishing adverse drug reactions.

资源简介：

相关数据集